2012
DOI: 10.1016/j.mcna.2012.04.011
|View full text |Cite
|
Sign up to set email alerts
|

The Importance of the Assessment of Pulmonary Function in COPD

Abstract: Synopsis Spirometry is the gold standard for making the diagnosis of COPD. It should be performed in every case of suspected COPD. Other pulmonary functions such as lung volumes can give you insight into physiological consequences of COPD such as hyperinflation. Pulmonary function testing can also aid in assessing the severity of disease and in managing the disease once the diagnosis is made.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
34
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(34 citation statements)
references
References 18 publications
0
34
0
Order By: Relevance
“…21 But pulmonary function is influenced by age, sex, height and ethnicity. 21 But pulmonary function is influenced by age, sex, height and ethnicity.…”
Section: Discussionmentioning
confidence: 99%
“…21 But pulmonary function is influenced by age, sex, height and ethnicity. 21 But pulmonary function is influenced by age, sex, height and ethnicity.…”
Section: Discussionmentioning
confidence: 99%
“…[5] Spirometry, which is widely available, is the easiest and most common method of testing pulmonary function. Spirometric indices, primarily forced expiratory volume in 1 sec (FEV1), are used to monitor progression and describe severity in chronic respiratory diseases such as cystic fibrosis or COPD [68]. In PCD patients, several studies have reported results of lung function measurements, however their findings are contradictory, ranging from normal lung function to significant impairment.…”
Section: Introductionmentioning
confidence: 99%
“…The DLCO provides clinical insights complimentary to those obtained by spirometry and lung volume measurements, for example, in discriminating asthma from chronic obstructive pulmonary disease (COPD), to identify causes of hypoxemia or dyspnoea, and to monitor patients with interstitial lung disease (3). DLCO is decreased in patients with emphysema due to a decrease in the total surface area of the lung and the loss of capillary beds (1,4). In contrast to the abundance of genome-wide association studies (GWAS) investigating genetic variation of spirometry measures (5)(6)(7)(8), the heritability of, and genetic influences on DLCO, are largely unknown.…”
Section: Introductionmentioning
confidence: 99%